ProPhase Labs, Inc. (PRPH)
NASDAQ: PRPH · Real-Time Price · USD
0.3274
-0.0266 (-7.51%)
At close: Aug 13, 2025, 4:00 PM
0.3235
-0.0039 (-1.19%)
After-hours: Aug 13, 2025, 7:05 PM EDT
ProPhase Labs Employees
ProPhase Labs had 96 employees as of December 31, 2024. The number of employees decreased by 17 or -15.04% compared to the previous year.
Employees
96
Change (1Y)
-17
Growth (1Y)
-15.04%
Revenue / Employee
$48,104
Profits / Employee
-$431,792
Market Cap
13.60M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PRPH News
- 11 hours ago - ProPhase Labs Announces Financial Results for the Three and Six Months Ended June 30, 2025 - GlobeNewsWire
- 1 day ago - ProPhase Labs Announces Full USPTO Approval for Issuance of U.S. Patent Protecting Esophageal Adenocarcinoma Risk Assessment - GlobeNewsWire
- 2 days ago - ProPhase Labs Inc. to Present Second Quarter 2025 Financial Results on August 13, 2025 - GlobeNewsWire
- 15 days ago - ProPhase Labs Announces Special Meeting of Shareholders and Filing of Preliminary Proxy Statement - GlobeNewsWire
- 21 days ago - ProPhase Labs Announces Closing of $3 Million Senior Secured Convertible Notes Financing - GlobeNewsWire
- 23 days ago - ProPhase Labs Board of Directors Authorizes Management to Explore Strategic Reverse Merger and Approves Crypto Treasury Initiative - GlobeNewsWire
- 6 weeks ago - ProPhase Labs, Inc. Receives Additional 180 Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule - GlobeNewsWire
- 2 months ago - ProPhase Labs Announces Successful Study Demonstrating Performance of BE-Smart™ Test in Detecting Esophageal Cancer - GlobeNewsWire